Join our smart investors - Get the best stock directories in  blockchain, cannabis, crypto, AI, IoT, cleantech. Daily podcasts in cannabis and crpto. Just $99  a year

CSE New Listing - NanoSphere Health Sciences Inc. (NSHS); @CSE_News


December 4, 2017 ( Newswire) The common shares of NanoSphere Health Sciences Inc. have been approved for listing on the CSE. Listing and disclosure documents will be available at on the trading date.

NanoSphere Health Sciences is a biotechnology company that has developed and is commercializing its patent-pending NanoSphere Delivery SystemTM, a ground breaking platform using nanotechnology for the delivery of biological agents such as cannabinoids, supplements, nutraceuticals and over-the-counter medications for the cannabis, pharmaceutical and animal health industries, and beyond. The NanoSphere Delivery SystemTM provides improved bioavailability, efficacy and onset of effect over traditional delivery systems, and represents one of the most important developments for advancing the non-invasive and user-friendly delivery of biological agents in over 25 years.

Under the brand name “Evolve”, NanoSphere has already launched its acclaimed NanoSerumTM product for the recreational and medical cannabis markets in Colorado, and plans to build on that success by opening new markets for Evolve and developing and commercializing new applications for NanoSerumTM.


L'inscription à la cote de CSE des actions ordinaires de NanoSphere Health Sciences Inc. a été approuvée.

Les documents d'inscription et de divulgation seront disponibles sur à la date de négociation.

NanoSphere Health Sciences est une société de biotechnologie qui a développé et commercialise son NanoSphere Delivery SystemTM, une plateforme révolutionnaire utilisant la nanotechnologie pour la distribution d'agents biologiques tels que les cannabinoïdes, les suppléments, les nutraceutiques et les médicaments en vente libre pour le cannabis. les industries de la santé pharmaceutique et animale, et au-delà. Le NanoSphere Delivery SystemTM offre une biodisponibilité, une efficacité et un effet d'efficacité améliorés par rapport aux systèmes d'administration traditionnels, et constitue l'un des développements les plus importants pour faire progresser la distribution non invasive et conviviale d'agents biologiques depuis plus de 25 ans.

Sous la marque "Evolve", NanoSphere a déjà lancé son célèbre produit NanoSerumTM pour les marchés du cannabis récréatif et médical au Colorado, et prévoit de tirer parti de ce succès en ouvrant de nouveaux marchés pour Evolve et en développant et commercialisant de nouvelles applications pour NanoSerumTM.

If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail:

Pour toute question, pour obtenir de l'information supplémentaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel à l'adresse:

About the CSE

The Canadian Securities Exchange, or CSE, is operated by CNSX Markets Inc. Recognized as a stock exchange in 2004, the CSE began operations in 2003 to provide a modern and efficient alternative for companies looking to access the Canadian public capital markets. is a listed service provider on the Canadian Securities Exchange - Investor Research for Nanotechnology Stocks - investing ideas in nanotechnology stocks

Like Nanotechnology Stocks? View our Nanotechnology Stocks Directory

More Info: Newswire

This news is published on the Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: Learn more about publishing your news release on the newswire

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: Global investors must adhere to regulations of each country.

Please read privacy policy: